Roivant Sciences Ltd.
ROIV
$11.92
$0.110.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.18% | -221.90% | -- | -- | 163.06% |
| Total Depreciation and Amortization | -86.55% | 320.17% | -- | -- | -85.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 729.08% | 97.32% | -- | -- | -1,720.37% |
| Change in Net Operating Assets | -207.57% | 164.94% | -- | -- | -607.68% |
| Cash from Operations | -18.44% | 16.74% | -- | -- | -77.79% |
| Capital Expenditure | -397.53% | 55.61% | -- | -- | -176.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -51.48% | -- | -- | -- |
| Other Investing Activities | -208.16% | 231.74% | -- | -- | -- |
| Cash from Investing | -201.07% | 136.57% | -- | -- | -113.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | 76.14% |
| Issuance of Common Stock | 131.72% | -53.86% | -- | -- | -37.87% |
| Repurchase of Common Stock | 28.09% | -20.21% | -- | -- | -2,210.26% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.99% | 35.10% | -- | -- | -1,924.94% |
| Foreign Exchange rate Adjustments | 266.67% | 54.17% | -- | -- | -220.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -304.02% | 2,762.21% | -- | -- | -534.89% |